Weikang Pharmaceutical: Announcement of Resolutions of the Seventh Meeting of the Fourth Supervisory Board
Securities code: 300878 Securities abbreviation: Weikang Pharmaceutical Announcement number: 2025-041
Zhejiang Weikang Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Seventh Meeting of the Fourth Supervisory Board
The Company and all members of the Supervisory Board guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.
1. Convening of Supervisory Board Meetings
Zhejiang Weikang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") issued the notice of the seventh meeting of the fourth session of the Supervisory Board by email, personal delivery or telephone on October 23, 2025. The meeting was held on-site on October 28, 2025 in the conference room of the R&D Building, No. 2 Suisong Road, Lishui Economic Development Zone, Zhejiang Province. There were 3 supervisors who should participate in the voting and 3 supervisors who actually participated in the voting. The meeting was chaired by Ye Zhixue, chairman of the company's supervisory board. The convening, holding and voting procedures of this meeting complied with the provisions of relevant laws, regulations, departmental rules, normative documents and the Articles of Association, and the resolutions formed at the meeting were legal and valid.
2. Review status of the Supervisory Board meeting
- Consideration and approval of the “Proposal on the Company’s Third Quarterly Report for 2025”
After review, the Board of Supervisors believes that: the board of directors' procedures for preparing and reviewing the company's 2025 third quarter report are in compliance with laws, administrative regulations and the provisions of the China Securities Regulatory Commission. The content of the report truly, accurately and completely reflects the actual situation of the company, and does not contain any false records, misleading statements or major omissions.
For details, please refer to the "Company's 2025 Third Quarter Report" disclosed by the company on the cninfo website (http://www.cninfo.com.cn) on the same day.
Voting results: 3 votes in favor, 0 votes against, 0 abstentions.
3. Documents for reference
Resolution of the seventh meeting of the fourth supervisory board of Zhejiang Weikang Pharmaceutical Co., Ltd.
Announcement is hereby made.
Board of Supervisors of Zhejiang Weikang Pharmaceutical Co., Ltd.
October 30, 2025